Pancreatic Cancer Research Initiative
Pancreatic cancer, one of the most serious
types of cancer, spreads rapidly and is rarely detected in its
early stages. It is the fourth leading cause of cancer
deaths in the United States and eighth globally. More
than half of all patients diagnosed with pancreatic cancer
worldwide have a five-year survival rate of less than two
percent.
Pancreatic cancer is expected to take the lives of 34,290 Americans this year, while a projected 37,680 will be newly diagnosed with the disease. The mortality rate has not declined in over 30 years.
Even when pancreatic cancer is localized, only 20 percent of patients survive at least five years. Patients who have surgery before the cancer metastasizes have the best chance of survival, but with no effective screening methods, only seven percent of these cancers are caught early.
The American-Italian Cancer Foundation (AICF) has launched a new Pancreatic Cancer Research Initiative (PCRI). Beginning in 2009, scientific researchers from the United States, Italy, and other parts of Europe will be eligible to receive funding for projects of up to three years in basic, translational, or genetic research as it applies to pancreatic cancer. PCRI grants will fund research that shows great promise for translating knowledge gained to prevention or new treatments and, ultimately, for prolonging and enhancing the life of pancreatic cancer patients. A minimum of $225,000 will be available in Spring 2010 for one or more awards.
Click to download the PCRI Research Grant Guidelines.
Click to download the PCRI Research Grant Application Cover
Sheet.
Donors wishing to contribute to PCRI's research
grant fund may designate their gifts in honor or in memory of
loved ones or friends.
To make a contribution to PCRI, please click here.
